• 검색 결과가 없습니다.

Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

N/A
N/A
Protected

Academic year: 2021

Share "Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis"

Copied!
7
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 2. Demographic and clinical features of the patients with ankylosing spondylitis receiving TNF inhibitors
Fig. 1. Survival curves of the TNF inhibitors in patients with rheumatoid arthritis (A) and ankylosing spondylitis (B).

참조

관련 문서

In addition, the expression of REDD1 was increased when Huh7 cells were treated with PA, and overexpression of REDD1 affected cell survival and lipid

Results: In this research, in the group with fibromyalgia patients group, systemic lupus erythematosus patients group and without systemic autoimmune

A retrospective analysis of invasive tumor percentages of GSS tumor samples showed that samples with high tumor content correlated well with FNAB samples

 Although van der Waals equation is still less accurate at high

Anti‑cyclic citrullinated peptide antibody testing is used to diagnose rheumatoid arthritis and associated with interstitial lung disease in RA.. Herein, we

Among the various pulmonary manifestations, interstitial lung disease (ILD) is known to be associated with substantial morbidity and mortality rates in RA patients.. As RA-ILD

In elderly metastatic colon cancer patients, the treatment results of combination therapy with targeted treatment showed similar results to those reported in clinical trials

The ‘Investigation of outcomes after GOLimumab Discon- tinuation,’ or GOLD, was an observational study involving 10 centers nationwide that analyzed clinical data